Ireland
--:--IST
Latest
Clinical Trials in France / NCT07671638
Starting soon Not applicable

Methodological Study of Exercise and Hypoxic Conditions in Healthy Subjects

NCT07671638 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-09-15
Last updated
2026-07-21

Condition(s) studied

Healthy Subjects (HS)ExerciseHypoxia

Investigational drug(s) / intervention(s)

Exercise and hypoxia

Exercise and hypoxia: Subjects will perform an exercise test while inhaling a hypoxic gas mixture

Study summary

The aim of this protocol is to assess physiological responses during various physical exercise protocols (whole-body exercise such as cycling or treadmill running, or localised exercise such as knee extension) and during inhalation of a gas mixtures with various oxygen contents (similar to exposure at high altitude).

Eligibility

Sex
ALL
Min age
18 Years
Max age
55 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy male or female volunteers * Aged 18-55 * Body Mass Index \<30 kg/m² * Participants covered by a social security scheme * Participants capable of signing an informed consent form * Negative pregnancy test and highly effective contraception for women of childbearing age Exclusion Criteria: * Cardiorespiratory, metabolic and neurological disorders, or other conditions assessed during the inclusion consultation that may affect physiological responses to exercise or hypoxia * Pharmacological treatment taken during the study, other than oral or implantable contraceptive medication for female volunteers of childbearing age

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CReSI (centre de recherche en santé intégrée) La Tronche France

More University Hospital, Grenoble trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07671638 on ClinicalTrials.gov ↗ ← All trials in France